RxDoctor Payments Data

Lisa Arehart, APRN

Nurse Practitioner · Crittenden, KYNPI 1730116823

Payments from drug & device makers

$5,630in general payments, 2019–2025

Across 368 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$657
  • Pfizer$530
  • GSK$439
  • Lilly USA, LLC$326
  • Exact Sciences$199
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$5,630100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,630 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$63,219
Medicare patients
306
Services billed
2,214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$90,988
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$54,356
MounjaroTirzepatide36$52,799
JardianceEmpagliflozin37$45,282
EliquisApixaban48$44,970
TrulicityDulaglutide19$37,598
MyrbetriqMirabegron45$29,330
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$26,272
Breo ElliptaFluticasone/Vilanterol51$25,095
XareltoRivaroxaban16$23,301
FarxigaDapagliflozin Propanediol26$19,826
JanuviaSitagliptin Phosphate18$19,397
Spiriva RespimatTiotropium Bromide19$19,008
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$12,651
Incruse ElliptaUmeclidinium Bromide23$8,097

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$439$100,200163 claims
Novo NordiskOzempic$657$90,98862 claims
Lilly USA, LLCMounjaro, Trulicity$326$90,39755 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$28$70,48168 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$20$49,82171 claims
PfizerEliquis, Paxlovid$530$46,33760 claims
Astellas Pharma US IncMyrbetriq$71$29,33045 claims
Johnson & JohnsonXarelto$108$23,30116 claims
MerckJanuvia$30$19,39718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Crittenden

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →